Article info
PDFOriginal research
Metronomic oral cyclophosphamide in relapsed ovarian cancer
- Correspondence to Dr Pavlina Spiliopoulou, Beatson West of Scotland Cancer Centre, Glasgow G12 0YN, UK; pavlina.spiliopoulou{at}glasgow.ac.uk
Citation
Metronomic oral cyclophosphamide in relapsed ovarian cancer
Publication history
- Received January 31, 2021
- Revision received May 5, 2021
- Accepted May 7, 2021
- First published May 20, 2021.
Online issue publication
January 10, 2022
Article Versions
- Previous version (10 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.